NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar

  • Written by ACN Newswire

image

SINGAPORE, May 31, 2018 - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market.Global BioLife...

Read more: Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global...